Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report

ObjectiveTo compare survival outcomes of type B radical hysterectomy (RH) and type C RH in patients with early-stage cervical cancer.MethodsWe retrospectively identified continuous cervical cancer patients with FIGO stage IA2-IB2 and IIA1 who underwent either type B RH (n = 278) or type C RH (n = 14...

Full description

Bibliographic Details
Main Authors: Lu Wang, Ping Liu, Hui Duan, Pengfei Li, Guidong Su, Weili Li, Cong Liang, Chunlin Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2023.1166084/full
_version_ 1797848201060941824
author Lu Wang
Ping Liu
Hui Duan
Pengfei Li
Guidong Su
Weili Li
Cong Liang
Chunlin Chen
author_facet Lu Wang
Ping Liu
Hui Duan
Pengfei Li
Guidong Su
Weili Li
Cong Liang
Chunlin Chen
author_sort Lu Wang
collection DOAJ
description ObjectiveTo compare survival outcomes of type B radical hysterectomy (RH) and type C RH in patients with early-stage cervical cancer.MethodsWe retrospectively identified continuous cervical cancer patients with FIGO stage IA2-IB2 and IIA1 who underwent either type B RH (n = 278) or type C RH (n = 148) performed by the same group of surgeons between 2009 and 2018. Propensity score matching was carried out to minimize selection biases. Intraoperative photographs, immediate postoperative questionnaire and specimen measurements were used to accurately determine the extensive of surgery. We further narrowed the study population to patients with specific histological subtypes and patients with deep stromal invasion.ResultsThe median follow-up period was 42.41 ± 24.60 months. After adjusting, no differences in the 5-year overall survival (OS) and disease-free survival (DFS) were found between the type B group and the type C group (OS: 87.8% vs. 89.4%, P = 0.814; DFS: 84.9% vs. 85.6%, P = 0.898). In further analysis of patients with squamous-cell carcinoma, adenocarcinoma, adenosquamous carcinoma, similar 5-year OS and DFS rates were found between two groups (OS: 88.7% vs. 97.1%, P = 0.250; DFS: 84.7% vs. 92.3%, P = 0.541). Consistent results were found in patients with deep stromal invasion (OS: 81.8% vs. 100%, P = 0.144; DFS: 82.8% vs. 100%, P = 0.128).ConclusionsType B RH could be used to treat FIGO stage IA2-IB2 and IIA1 cervical cancer to get equivalent 5-year OS and DFS. Further randomized controlled trials are warranted.
first_indexed 2024-04-09T18:24:41Z
format Article
id doaj.art-c2ff84ad966b431bbb0ff02e3bf3fa71
institution Directory Open Access Journal
issn 2296-875X
language English
last_indexed 2024-04-09T18:24:41Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj.art-c2ff84ad966b431bbb0ff02e3bf3fa712023-04-12T05:22:44ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2023-04-011010.3389/fsurg.2023.11660841166084Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort reportLu WangPing LiuHui DuanPengfei LiGuidong SuWeili LiCong LiangChunlin ChenObjectiveTo compare survival outcomes of type B radical hysterectomy (RH) and type C RH in patients with early-stage cervical cancer.MethodsWe retrospectively identified continuous cervical cancer patients with FIGO stage IA2-IB2 and IIA1 who underwent either type B RH (n = 278) or type C RH (n = 148) performed by the same group of surgeons between 2009 and 2018. Propensity score matching was carried out to minimize selection biases. Intraoperative photographs, immediate postoperative questionnaire and specimen measurements were used to accurately determine the extensive of surgery. We further narrowed the study population to patients with specific histological subtypes and patients with deep stromal invasion.ResultsThe median follow-up period was 42.41 ± 24.60 months. After adjusting, no differences in the 5-year overall survival (OS) and disease-free survival (DFS) were found between the type B group and the type C group (OS: 87.8% vs. 89.4%, P = 0.814; DFS: 84.9% vs. 85.6%, P = 0.898). In further analysis of patients with squamous-cell carcinoma, adenocarcinoma, adenosquamous carcinoma, similar 5-year OS and DFS rates were found between two groups (OS: 88.7% vs. 97.1%, P = 0.250; DFS: 84.7% vs. 92.3%, P = 0.541). Consistent results were found in patients with deep stromal invasion (OS: 81.8% vs. 100%, P = 0.144; DFS: 82.8% vs. 100%, P = 0.128).ConclusionsType B RH could be used to treat FIGO stage IA2-IB2 and IIA1 cervical cancer to get equivalent 5-year OS and DFS. Further randomized controlled trials are warranted.https://www.frontiersin.org/articles/10.3389/fsurg.2023.1166084/fullcervical cancerearly-stagetype b radical hysterectomysurvival outcomeparametrectomy
spellingShingle Lu Wang
Ping Liu
Hui Duan
Pengfei Li
Guidong Su
Weili Li
Cong Liang
Chunlin Chen
Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report
Frontiers in Surgery
cervical cancer
early-stage
type b radical hysterectomy
survival outcome
parametrectomy
title Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report
title_full Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report
title_fullStr Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report
title_full_unstemmed Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report
title_short Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report
title_sort abdominal type b vs type c radical hysterectomy in early stage cervical cancer a matched single center cohort report
topic cervical cancer
early-stage
type b radical hysterectomy
survival outcome
parametrectomy
url https://www.frontiersin.org/articles/10.3389/fsurg.2023.1166084/full
work_keys_str_mv AT luwang abdominaltypebvstypecradicalhysterectomyinearlystagecervicalcanceramatchedsinglecentercohortreport
AT pingliu abdominaltypebvstypecradicalhysterectomyinearlystagecervicalcanceramatchedsinglecentercohortreport
AT huiduan abdominaltypebvstypecradicalhysterectomyinearlystagecervicalcanceramatchedsinglecentercohortreport
AT pengfeili abdominaltypebvstypecradicalhysterectomyinearlystagecervicalcanceramatchedsinglecentercohortreport
AT guidongsu abdominaltypebvstypecradicalhysterectomyinearlystagecervicalcanceramatchedsinglecentercohortreport
AT weilili abdominaltypebvstypecradicalhysterectomyinearlystagecervicalcanceramatchedsinglecentercohortreport
AT congliang abdominaltypebvstypecradicalhysterectomyinearlystagecervicalcanceramatchedsinglecentercohortreport
AT chunlinchen abdominaltypebvstypecradicalhysterectomyinearlystagecervicalcanceramatchedsinglecentercohortreport